FDA Adverse Event Malfunction Summary report: N

PRIMARY PLUMSET¿, CLAVE¿ PORT, CLAVE¿ Y-SITE

MDR report key: 3242258 · Received July 15, 2013

Report

Report Number
3242258
Event Type
Malfunction
Date Received
July 15, 2013
Date of Event
June 11, 2013
Report Date
July 11, 2013
Manufacturer
HOSPIRA, INC.
Product Code
FPA
Product Problem
Yes
Report Source
User Facility report
Reporter Location
MA, US

Narratives

Description of Event or Problem · 1

PATIENT RECEIVED 3 PRE-MEDS THROUGH SECONDARY LINE. WHEN CHEMO CONNECTED, WOULD NOT RUN. THIS HAS HAPPENED TWICE BEFORE AND WE HAVE ELIMINATED THE DIFFERENT SOURCES (PUMP, AIR IN LINE, TUBING ON CHEMO, ETC). IT SEEMS AS IF THE PRIMARY TUBING IS MALFUNCTIONING AT THE SECONDARY CLAVE. ONCE THE PRIMARY TUBING IS CHANGED, THE INFUSION CONTINUES WITHOUT PROBLEM.WHAT WAS THE ORIGINAL INTENDED PROCEDURE?MEDICATION FOR CANCER PATIENT.DEVICE #1IS THIS A LABORATORY DEVICE OR LABORATORY TEST?NO.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
327505 PRIMARY PLUMSET¿, CLAVE¿ PORT, CLAVE¿ Y-SITE IV ADMINISTRATION SET FPA HOSPIRA, INC. * *

Patients

Seq Age Sex Outcome Treatment
1 72 YR HAS HAPPENED TWICE BEFORE AND WE HAVE ELIMINATED| IS MALFUNCTIONING AT THE SECONDARY CLAVE. ONCE THE| ON CHEMO, ETC). IT SEEMS AS IF THE PRIMARY TUBING| WERE REPLACED UNTIL ISSUE WAS RESOLVED. "THIS| THERE WERE OTHER DEVICES BEING USED. ALL DEVICES| THE DIFFERENT SOURCES (PUMP, AIR IN LINE, TUBING| WITHOUT PROBLEM."| PRIMARY TUBING IS CHANGED, THE INFUSION CONTINUES